estrone has been researched along with formestane in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (41.67) | 18.7374 |
1990's | 9 (37.50) | 18.2507 |
2000's | 3 (12.50) | 29.6817 |
2010's | 2 (8.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Bellavance, E; Luu-The, V; Poirier, D | 1 |
Barmade, MA; Murumkar, PR; Tamboli, RS; Yadav, MR | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Dowsett, M; Jacobs, S; Jones, AL; Lonning, PE; MacNeill, F; Powles, TJ | 1 |
Aherne, GW; Chakraborty, J; Ghilchik, MW; Patel, S; Reed, MJ | 1 |
Ayub, M; Levell, MJ | 1 |
Coldham, NG; Ghilchik, MW; James, VH; Lai, LC; Owen, AM; Purohit, A; Reed, MJ; Shaikh, NA; Singh, A | 1 |
Bartsch, W; Klein, H; Stürenburg, HJ; Voigt, KD | 1 |
Coldham, NG; Ghilchik, MW; James, VH; Lai, LC; Owen, AM; Reed, MJ; Shaikh, NA | 1 |
Oakey, RE; Purohit, A | 1 |
Coombes, RC; Cunningham, DC; Dehennin, L; Dowsett, M; Evans, S; Hedley, A; Stein, RC | 1 |
Brodie, AM; Coombes, RC; Dowsett, M; Gazet, JC; Goss, PE; Hutchison, G; Powles, TJ | 1 |
Longcope, C; Mordes, JP; Orczyk, GP | 1 |
Feil, PD; Leszczynski, D; Manni, A; Santen, RJ; Santner, SJ; Tilson-Mallet, N; Wright, C | 1 |
Gelly, C; Pasqualini, JR; Sumida, C | 1 |
Feil, PD; Santen, RJ; Santner, SJ; Tilson-Mallett, N | 1 |
Abul-Hajj, YJ | 1 |
Reed, MJ | 1 |
Bhatnagar, AS; King, EJ; Purba, HS; Richert, P | 1 |
Ekse, D; Lønning, PE | 1 |
Amichetti, M; Attili, A; Bajetta, E; Barni, S; Bichisao, E; Bolelli, GF; Bombardieri, E; Buzzoni, R; Comella, G; D'Aprile, M; Ferrari, L; Jirillo, A; Martinetti, A; Noberasco, C; Schieppati, G; Zilembo, N | 1 |
Bonneterre, J; Feutrie, ML | 1 |
4 review(s) available for estrone and formestane
Article | Year |
---|---|
Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer.
Topics: Aromatase; Aromatase Inhibitors; Breast Neoplasms; Drug Design; Female; Humans; Models, Molecular; Molecular Structure | 2015 |
Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
Topics: 17-Hydroxysteroid Dehydrogenases; Adrenalectomy; Aminoglutethimide; Androstenedione; Animals; Aromatase; Breast Neoplasms; Estradiol; Estrogens; Estrone; Female; Humans; Hydrocortisone; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Rats; Sulfatases; Testolactone | 1986 |
The role of aromatase in breast tumors.
Topics: Androstenedione; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; DNA Polymerase II; Estrogens; Estrone; Female; Humans; Prognosis; Receptors, Progesterone; Tumor Cells, Cultured | 1994 |
[Aromatase inhibitors].
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Estrogen Antagonists; Estrone; Female; Humans; Letrozole; Nitriles; Triazoles | 1999 |
2 trial(s) available for estrone and formestane
Article | Year |
---|---|
Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients.
Topics: Administration, Oral; Androstenedione; Breast Neoplasms; Dose-Response Relationship, Drug; Estradiol; Estrone; Female; Half-Life; Humans; Injections, Intramuscular; Menopause; Sex Hormone-Binding Globulin | 1989 |
A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: endocrine and clinical results. The Italian Trials in Medical Oncology (I.T.M.O.) group.
Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Injections, Intramuscular; Middle Aged; Postmenopause; Survival Analysis; Treatment Outcome | 1997 |
18 other study(ies) available for estrone and formestane
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
Topics: 17-Hydroxysteroid Dehydrogenases; Androstane-3,17-diol; Androstanes; Biocatalysis; Cell Line; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrone; Humans; Inhibitory Concentration 50; Oxidation-Reduction; Substrate Specificity | 2009 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
The influence of intramuscular 4-hydroxyandrostenedione on peripheral aromatisation in breast cancer patients.
Topics: Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Dose-Response Relationship, Drug; Estradiol; Estriol; Estrone; Female; Humans; Injections, Intramuscular; Middle Aged | 1992 |
Concentrations of oestrone and 4-hydroxyandrostenedione in malignant and normal breast tissues.
Topics: Aged; Androstenedione; Aromatase Inhibitors; Breast; Breast Neoplasms; DNA Polymerase II; Estrone; Female; Humans; Neoplasm Staging | 1991 |
The inhibition of human prostatic aromatase activity by imidazole drugs including ketoconazole and 4-hydroxyandrostenedione.
Topics: Androstenedione; Aromatase Inhibitors; Estradiol; Estrone; Humans; Imidazoles; Ketoconazole; Male; Prostate; Structure-Activity Relationship | 1990 |
Effect of treatment with 4-hydroxyandrostenedione on the peripheral conversion of androstenedione to estrone and in vitro tumor aromatase activity in postmenopausal women with breast cancer.
Topics: Aged; Androstenedione; Antineoplastic Agents; Aromatase; Breast Neoplasms; DNA Polymerase II; Estrone; Female; Humans; Kinetics; Metabolic Clearance Rate | 1990 |
Metabolism of androgens in human benign prostatic hyperplasia: aromatase and its inhibition.
Topics: 17-Hydroxysteroid Dehydrogenases; Androgens; Androstenedione; Aromatase; Aromatase Inhibitors; Estrone; Humans; Male; Microsomes; Placenta; Prostate; Prostatic Hyperplasia; Testolactone | 1987 |
In situ oestrone synthesis in normal breast and breast tumour tissues: effect of treatment with 4-hydroxyandrostenedione.
Topics: Aged; Androstenedione; Aromatase; Breast; Breast Neoplasms; DNA Polymerase II; Estrone; Female; Humans; Middle Aged | 1989 |
Evidence for separate sites for aromatisation of androstenedione and 16 alpha-hydroxyandrostenedione in human placental microsomes.
Topics: Androstenedione; Aromatase; Aromatase Inhibitors; Estradiol; Estriol; Estrone; Female; Humans; Hydroxyestrones; In Vitro Techniques; Kinetics; Microsomes; Placenta; Pregnancy; Radioimmunoassay | 1989 |
Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report.
Topics: Adult; Aged; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Dehydroepiandrosterone; Drug Evaluation; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Sex Hormone-Binding Globulin | 1986 |
Aromatase activity in a rat Leydig cell tumor.
Topics: Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Bucladesine; Chorionic Gonadotropin; Dihydrotestosterone; Estradiol; Estrone; Leydig Cell Tumor; Male; Neoplasm Transplantation; Rats; Rats, Inbred WF; Testicular Neoplasms; Testosterone; Tetradecanoylphorbol Acetate; Water | 1987 |
4-Hydroxyandrostenedione is not an aromatase inhibitor in the neonatal guinea pig.
Topics: Androstenedione; Animals; Animals, Newborn; Aromatase Inhibitors; Estradiol; Estrone; Female; Guinea Pigs; Organ Culture Techniques; Organ Size; Receptors, Estrogen; Receptors, Progesterone; Uterus | 1987 |
Biological significance of aromatase activity in human breast tumors.
Topics: Aminoglutethimide; Androstenedione; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Estrone; Female; Humans; Oxidoreductases; Receptors, Estrogen; Receptors, Progesterone; Testolactone | 1983 |
Inhibition of androgen aromatization in human breast cancer.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Carbon Radioisotopes; Estradiol; Estrone; Female; Humans; Kinetics; Microsomes; Oxidoreductases; Placenta; Pregnancy | 1980 |
Effect of aromatase inhibitors on estrogen 2-hydroxylase in rat liver.
Topics: Aminoglutethimide; Androstenedione; Animals; Aromatase Inhibitors; Binding, Competitive; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Estradiol; Estrone; Fadrozole; Female; Ketoconazole; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Steroid Hydroxylases; Substrate Specificity | 1994 |
A sensitive assay for measurement of plasma estrone sulphate in patients on treatment with aromatase inhibitors.
Topics: Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrone; Female; Humans; Hydrolysis; Menopause; Radioimmunoassay; Sensitivity and Specificity | 1995 |